- Supported exchanges /
- LSE /
- 0QLQ.LSE
Ypsomed Holding AG (0QLQ LSE) stock market data APIs
Ypsomed Holding AG, together with its subsidiaries, develops, manufactures, and sells injection and infusion systems for pharmaceutical and biotechnology companies. The company operates through two segments, Ypsomed Delivery Systems and Ypsomed Diabetes Care. The Ypsomed Delivery Systems segment provides various injection systems, such as pen injectors, auto injectors, and wearable injectors, as well as other smart devices. This segment offers its products under the YDS brand. The Ypsomed Diabetes Care segment sells and trades in insulin pumps, infusion sets, pen needles, blood glucose monitoring systems, accessories, and other day-to-day items for diabetics. This segment offers its products under the mylife brand name. The company offers precision turned parts; and contract manufacturing and other services. It markets its products through pharmaceutical partners, as well as through its own distribution network and independent distributors. It operates in Switzerland, Europe, North America, and internationally. Ypsomed Holding AG was founded in 1984 and is headquartered in Burgdorf, Switzerland.
Ypsomed Holding AG Financial Data Overview
424.5 | |
423.5 | |
- | |
428 | |
423.5 | |
243.4942-434.5 | |
5 308 M | |
2.3235 | |
12 603 K | |
548 M | |
0.0047 | |
0.973 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
Ypsomed Holding AG Fundamental Data is available in our Financial Data APIs
- Net Revenue 548 M
- EBITDA 133 M
- Earnings Per Share 1.827
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get Ypsomed Holding AG Earnings via APIs
- Latest Release 2024-05-22
- EPS/Forecast NaN
Get Ypsomed Holding AG End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also: